HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Lyandres Selected Research

Trastuzumab (Herceptin)

7/2016Adaptive Randomization of Neratinib in Early Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Lyandres Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
07/2016 - 07/2016
2Neoplasms (Cancer)
07/2016 - 07/2016
1Residual Neoplasm
07/2016
1Triple Negative Breast Neoplasms
07/2016

Drug/Important Bio-Agent (IBA)

2Hormones (Hormone)IBA
07/2016 - 07/2016
1Biomarkers (Surrogate Marker)IBA
07/2016
1Carboplatin (JM8)FDA LinkGeneric
07/2016
1neratinibIBA
07/2016
1human ERBB2 proteinIBA
07/2016
1veliparibIBA
07/2016
1Trastuzumab (Herceptin)FDA Link
07/2016

Therapy/Procedure

2Neoadjuvant Therapy
07/2016 - 07/2016
2Therapeutics
07/2016 - 07/2016
1Drug Therapy (Chemotherapy)
07/2016